Avastin (bevacizumab), Macugen (pegaptanib) en Lucentis (ranibizumab): vergelijking van medicatiekosten

Lucas Goossens, PD Knoester, MP Rutten-van Mölken

Research output: Contribution to journal › Article › Academic

2 Citations (Scopus)

Cite this

@article{a7c10317374d470389ea1a78293c8bb7,

title = "Avastin (bevacizumab), Macugen (pegaptanib) en Lucentis (ranibizumab): vergelijking van medicatiekosten",

author = "Lucas Goossens and PD Knoester and {Rutten-van M{\"o}lken}, MP",

year = "2008",

language = "Dutch",

volume = "2",

pages = "75--79",

journal = "Pharmaceutisch Weekblad",

issn = "0031-6911",

publisher = "Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)",

number = "4",

}